Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance Watch: Is The IPO Boom Making Anyone Nervous Yet?

Executive Summary

Public Company Edition: Is the IPO bubble getting ready to burst? It's anybody's guess, but biopharma companies are forging ahead, having launched 11 first-time offerings during the past week and a half. Also, Heron leads recent follow-on offerings with a $200m stock sale to fund what may soon be its third commercial product.

Advertisement

Related Content

Venture Funding Deals: Four $100m-Plus Rounds, Including Allogene's $300m
Finance Watch: VC Investment Soars In Q1, Putting Biopharma On Track For A Record Year
Finance Watch: Despite Bad News, IPOs And Public Offerings Keep Flowing
Finance Watch: Another Mega-Round As Moderna Bucks Biopharma's IPO Trend
Forty Seven's IO Antibody Attracts Two Big Pharma Partners
Aptinyx Reaches Milestones, Raises $70m To Develop NMDA Modulators
Autolus Raises $80m To Take T-Cell Engineering To The Next Level
Finance Watch: Former GSK CEO Witty, R&D Head Slaoui Join VC Firms
The Next Roivant Or Fortress? BridgeBio Raises $135m To Spin Out New Companies
Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123328

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel